Disruptive Pharma Seeks Drug Development Partnerships at BIO-Europe
Disruptive Pharma is attending BIO-Europe to seek partnerships for oral drug development.
Related stories
BorgWarner shares fall as sales forecast range narrows and Q3 revenue misses
BorgWarner’s sales forecast top end was trimmed, and third-quarter revenue missed expectations.
M impact | EQUITY | Oct 29, 2026, 02:59 PM UTC
Canada stocks fall as miner earnings disappoint and Alphabet weighs on tech
Canada's TSX is lower as miner earnings disappoint and Alphabet drags technology shares.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Ibn Al Haytham Hospital Reports Q3 Revenue of 3.1 Million Dinars
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Landmark Bancorp Q3 2026 Earnings Call Begins
Landmark Bancorp's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Broadstone Net Lease Q3 2026 Earnings Call Begins
Broadstone Net Lease's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC
Forestar Group’s Q4 2026 Earnings Call Begins
Forestar Group’s quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 02:57 PM UTC